Highnoon Laboratories Ltd
Hira Khan currently serves as a Senior Officer in Regulatory Affairs at Highnoon as of February 2024. Previously, Hira held the position of Regulatory Affairs Executive at Pharmasol (Pvt) Ltd. from October 2022 to January 2024, where responsibilities included preparing dossiers for various international markets and managing drug manufacturing license renewals. Hira also worked at Remington Pharmaceutical Industries from February 2021 to October 2022 as a Regulatory Affairs Officer and Drug Safety Officer, focusing on the compilation of registration dossiers for new drug products and the renewal of existing registrations. Academically, Hira is pursuing an MPhil in Pharmaceutical Chemistry at Punjab University College of Pharmacy, following the completion of a Doctor of Pharmacy (PharmD) degree from the same institution.
This person is not in the org chart
Highnoon Laboratories Ltd
Highnoon Laboratories Limited is a Pakistan-based pharmaceutical company. The Company is principally engaged in the manufacture, import, sale and marketing of pharmaceutical and allied consumer products. The Company offers products for various therapeutic areas, such as alimentary tract and metabolism, cardiovascular and respiratory products. The Company's product brands for alimentary tract and metabolism include Tres Orix Forte, Ulsanic, Skilax and Tagipmet. The Company's cardiovascular portfolio includes Misar brand, which is an angiotensin receptor blocker (ARB) used in the management of hypertension. Its products include AIRTAL (Aceclofenac), which has non-steroidal, anti-inflammatory and analgesic properties; ARIA (ketotifen), a non-bronchodilator antiasthamatic drug; ARTECXCIN, which acts as a blood schizotocide, and artrodar (diacerein), used for the treatment of inflammation and rheumatism. Its other products include Asthavent, AXESOME, Bezisox and Betatec.